These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 27356739)

  • 1. Aurora kinase A revives dormant laryngeal squamous cell carcinoma cells via FAK/PI3K/Akt pathway activation.
    Yang LY; He CY; Chen XH; Su LP; Liu BY; Zhang H
    Oncotarget; 2016 Jul; 7(30):48346-48359. PubMed ID: 27356739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the FAK/PI3K pathway is crucial for AURKA-induced epithelial-mesenchymal transition in laryngeal cancer.
    Yang L; Zhou Q; Chen X; Su L; Liu B; Zhang H
    Oncol Rep; 2016 Aug; 36(2):819-26. PubMed ID: 27373675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aurora kinase A induces chemotherapy resistance through revival of dormant cells in laryngeal squamous cell carcinoma.
    Yang LY; Shan YM; Zhang Y; Zhou EH; Chen XP; Zhang H
    Head Neck; 2019 Jul; 41(7):2239-2248. PubMed ID: 30706572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AURKA promotes cell migration and invasion of head and neck squamous cell carcinoma through regulation of the AURKA/Akt/FAK signaling pathway.
    Wu J; Yang L; Shan Y; Cai C; Wang S; Zhang H
    Oncol Lett; 2016 Mar; 11(3):1889-1894. PubMed ID: 26998095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
    Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS
    Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Full-length spleen tyrosine kinase inhibits the invasion and metastasis of human laryngeal squamous cell carcinoma.
    Li Z; Cai Z; Tao B; Jin Q
    Int J Clin Exp Pathol; 2015; 8(12):15786-93. PubMed ID: 26884848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CH25H Promotes Autophagy and Regulates the Malignant Progression of Laryngeal Squamous Cell Carcinoma Through the PI3K-AKT Pathway.
    Xiang Z; Yu S; Xu Y; Xiong H; Hu D; Li Q; Wu Z
    Cancer Med; 2024 Oct; 13(20):e70312. PubMed ID: 39428922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteolin enhances drug chemosensitivity by downregulating the FAK/PI3K/AKT pathway in paclitaxel‑resistant esophageal squamous cell carcinoma.
    Yang Z; Liu H; Song Y; Gao N; Gao P; Hui Y; Li Y; Fan T
    Int J Mol Med; 2024 Sep; 54(3):. PubMed ID: 38994756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation.
    Li Z; Yang Z; Passaniti A; Lapidus RG; Liu X; Cullen KJ; Dan HC
    Oncotarget; 2016 May; 7(22):31892-906. PubMed ID: 26895469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircCDK1 blocking IGF2BP2-mediated m6A modification of CPPED1 promotes laryngeal squamous cell carcinoma metastasis via the PI3K/AKT signal pathway.
    Li J; Cao H; Yang J; Wang B
    Gene; 2023 Oct; 884():147686. PubMed ID: 37543219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-144-3p, a tumor suppressive microRNA targeting ETS-1 in laryngeal squamous cell carcinoma.
    Zhang SY; Lu ZM; Lin YF; Chen LS; Luo XN; Song XH; Chen SH; Wu YL
    Oncotarget; 2016 Mar; 7(10):11637-50. PubMed ID: 26826553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DKK3 Overexpression Increases the Malignant Properties of Head and Neck Squamous Cell Carcinoma Cells.
    Katase N; Nishimatsu SI; Yamauchi A; Yamamura M; Terada K; Itadani M; Okada N; Hassan NMM; Nagatsuka H; Ikeda T; Nohno T; Fujita S
    Oncol Res; 2018 Jan; 26(1):45-58. PubMed ID: 28470144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
    Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
    J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tra2β silencing suppresses cell proliferation in laryngeal squamous cell carcinoma via inhibiting PI3K/AKT signaling.
    Ni HS; Hu SQ; Chen X; Liu YF; Ni TT; Cheng L
    Laryngoscope; 2019 Sep; 129(9):E318-E328. PubMed ID: 30597574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
    Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
    BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin, a potential inhibitor of MMP-2 in human laryngeal squamous carcinoma cells HEp2.
    Mitra A; Chakrabarti J; Banerji A; Chatterjee A; Das BR
    J Environ Pathol Toxicol Oncol; 2006; 25(4):679-90. PubMed ID: 17341208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non‑coding RNA fer‑1‑like family member 4 serves as a tumor suppressor in laryngeal squamous cell carcinoma cells via regulating the AKT/ERK signaling pathway.
    Jiao L; Liu S; Liu L; Hao P; Gong Z; Yan Z; Xiang Y
    Mol Med Rep; 2020 Dec; 22(6):5304-5312. PubMed ID: 33174027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of DJ-1 silencing by RNA interference on growth of xenografted human laryngeal squamous cell carcinoma Hep-2 cells in nude mice].
    Shen Z; Deng H; Ye D; Zhang J; Qiu S; Li Q; Cui X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(4):349-355. PubMed ID: 27868407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluid shear stress induces epithelial-mesenchymal transition (EMT) in Hep-2 cells.
    Liu S; Zhou F; Shen Y; Zhang Y; Yin H; Zeng Y; Liu J; Yan Z; Liu X
    Oncotarget; 2016 May; 7(22):32876-92. PubMed ID: 27096955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-340 impedes the progression of laryngeal squamous cell carcinoma by targeting EZH2.
    Yu W; Zhang G; Lu B; Li J; Wu Z; Ma H; Wang H; Lian R
    Gene; 2016 Feb; 577(2):193-201. PubMed ID: 26656176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.